The Vector W8 arrived as if it had slipped through a wormhole from a stranger, faster future, a low, angular projectile that ...

AI is changing search, but traditional SEO still drives most traffic. Real-world data shows which tactics continue to perform ...

This year’s best and most-read stories range from investigative pieces to unforgettable personal narratives. These are the ...

Here's a helmet at the more budget end of the market that I have been using for night time riding recently - it has a number of unique features and twists up its sleeve....but is it any good? Stay ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

An 'automated attacker' mimics the actions of human hackers to test the browser's defenses against prompt injection attacks. But there's a catch.

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.

Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. BioMarin Pharmaceuticals Inc.

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

In a CiOL interaction, Superteams.ai Founder Soum Paul breaks down enterprise AI adoption, fractional AI teams, governance ...